STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #149 by analyst upside · 2026-06-27
MDXH
MDxHealth SA
Healthcare · Market Cap $22M · P/E 0x
ANALYST PRICE TARGET
+579.5%
implied upside to consensus target
Current Price $0.43
Consensus Target $2.9
Bull Target $5.0
Bear Target $1.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
5
Hold
0
Sell
0
52-Week Low $0.42
52-Week High $5.33
YTD Return -87.6%
FUNDAMENTALS
Market Cap $22M
P/E Ratio (TTM) N/A
Forward P/E -1.1x
EPS (TTM) $-0.63
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $111M
Profit Margin -29.9%
52-WEEK RANGE
52-Week Low $0.42
52-Week High $5.33
Current Price $0.43
Bear Target $1.0
Bull Target $5.0
● Now $0.43 ● Target $2.9
TRADING DATA
Avg Volume 716K
YTD Return -87.6%
Analyst Count 5
Consensus Buy
Upside to Target +579.5%
Last Updated 2026-06-27

ANALYST SUMMARY

MDxHealth SA (MDXH) is currently trading at $0.43 with a Wall Street consensus price target of $2.9, implying potential upside of 579.5% over the next 12 months. 5 analysts currently cover MDXH, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $5.0, while the most cautious has a target of $1.0.

MDXH operates in the Healthcare sector with a market capitalisation of $22M. The stock is down 87.6% year-to-date and is currently trading near the lower end of its 52-week range of $0.42 – $5.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MDXH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Lake Street — Reiterated
Buy → Buy 2026-05-14 27% win rate (11 calls)
TD Cowen — Reiterated
Buy → Buy 2026-05-14 Building track record
BTIG — Reiterated
Buy → Buy 2026-05-14 38% win rate (8 calls)
BTIG reit
Buy → Buy 2025-12-23 38% win rate (8 calls)
TD Cowen — Reiterated
Buy → Buy 2025-11-13 Building track record
Lake Street — Reiterated
Buy → Buy 2025-11-13 27% win rate (11 calls)
BTIG — Reiterated
Buy → Buy 2025-11-13 38% win rate (8 calls)
Piper Sandler — Reiterated
Overweight → Overweight 2024-11-07 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
14/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →